ALBIO — Biosynex SA Cashflow Statement
0.000.00%
Last trade - 00:00- €25.25m
- €77.27m
- €92.98m
- 50
- 76
- 15
- 41
Annual cashflow statement for Biosynex SA, fiscal year end - December 31st, millions except per share.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | — | FAS | FAS | FAS | FAS |
| Status: | fx Preliminary | Final | Final | Final | Final |
| Net Income/Starting Line | — | 31.4 | 107 | 21.2 | -35.6 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | — | 0.001 | 0.031 | -0.008 | -0.017 |
| Unusual Items | |||||
| Changes in Working Capital | — | -7.18 | 0.578 | -37.3 | 14.5 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | — | 31.6 | 110 | 4.95 | -9.65 |
| Capital Expenditures | — | -9.12 | -19 | -37.8 | -39.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 1.19 | -9.95 | -9 | -15.3 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -7.93 | -29 | -46.8 | -54.8 |
| Financing Cash Flow Items | — | 0.154 | -1.78 | -21.2 | 0.808 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | 10.6 | 14.4 | -10.8 | 5.17 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | — | 34.3 | 95.3 | -52.6 | -59.3 |